Ubs Group Ag Cytokinetics Inc Transaction History

Ubs Group Ag

  • $611 Billion
  • Q3 2025

A detailed history of Ubs Group Ag transactions in Cytokinetics Inc stock. As of the latest transaction made, Ubs Group Ag holds 1,803,251 shares of CYTK stock, worth $120 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,803,251
Previous 3,070,665 41.27%
Holding current value
$120 Million
Previous $101 Million 2.31%
% of portfolio
0.02%
Previous 0.02%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025
SELL
$33.23 - $54.96 $42.1 Million - $69.7 Million
-1,267,414 Reduced 41.27%
1,803,251 $99.1 Million
Q2 2025

Aug 14, 2025
BUY
$29.84 - $42.92 $27.9 Million - $40.2 Million
936,446 Added 43.88%
3,070,665 $101 Million
Q1 2025

May 13, 2025
BUY
$40.19 - $51.12 $37.5 Million - $47.7 Million
932,220 Added 77.56%
2,134,219 $85.8 Million
Q4 2024

Feb 14, 2025
BUY
$46.36 - $58.62 $41.2 Million - $52.1 Million
888,440 Added 283.34%
1,201,999 $56.5 Million
Q3 2024

Nov 14, 2024
BUY
$51.22 - $60.16 $714,775 - $839,532
13,955 Added 4.66%
313,559 $16.6 Million
Q2 2024

Aug 13, 2024
BUY
$47.86 - $75.05 $41,159 - $64,543
860 Added 0.29%
299,604 $16.2 Million
Q1 2024

May 13, 2024
BUY
$63.75 - $108.06 $1.56 Million - $2.64 Million
24,436 Added 8.91%
298,744 $20.9 Million
Q4 2023

Feb 09, 2024
BUY
$26.88 - $83.49 $2.09 Million - $6.48 Million
77,637 Added 39.48%
274,308 $22.9 Million
Q3 2023

Nov 09, 2023
SELL
$29.46 - $36.61 $3.09 Million - $3.84 Million
-104,833 Reduced 34.77%
196,671 $5.79 Million
Q2 2023

Aug 11, 2023
BUY
$32.62 - $40.75 $1.67 Million - $2.09 Million
51,174 Added 20.44%
301,504 $9.84 Million
Q1 2023

May 12, 2023
SELL
$33.36 - $45.71 $2.83 Million - $3.88 Million
-84,887 Reduced 25.32%
250,330 $8.81 Million
Q4 2022

Feb 08, 2023
BUY
$35.77 - $51.11 $4.45 Million - $6.35 Million
124,320 Added 58.95%
335,217 $15.4 Million
Q3 2022

Nov 10, 2022
BUY
$38.54 - $54.52 $1.79 Million - $2.53 Million
46,415 Added 28.22%
210,897 $10.2 Million
Q2 2022

Aug 10, 2022
SELL
$33.93 - $48.92 $2.83 Million - $4.09 Million
-83,540 Reduced 33.68%
164,482 $6.46 Million
Q1 2022

May 16, 2022
BUY
$29.74 - $46.0 $108,521 - $167,854
3,649 Added 1.49%
248,022 $9.13 Million
Q4 2021

Feb 14, 2022
BUY
$34.35 - $46.38 $3.77 Million - $5.1 Million
109,869 Added 81.68%
244,373 $11.1 Million
Q3 2021

Nov 15, 2021
BUY
$18.54 - $35.74 $2 Million - $3.85 Million
107,854 Added 404.71%
134,504 $4.81 Million
Q2 2021

Aug 13, 2021
SELL
$19.79 - $26.99 $1.22 Million - $1.66 Million
-61,604 Reduced 69.8%
26,650 $528,000
Q1 2021

May 12, 2021
BUY
$18.57 - $25.68 $1.58 Million - $2.19 Million
85,091 Added 2690.2%
88,254 $2.05 Million
Q4 2020

Feb 11, 2021
BUY
$15.26 - $28.61 $9,949 - $18,653
652 Added 25.97%
3,163 $66,000
Q3 2020

Nov 12, 2020
BUY
$20.58 - $28.96 $3,272 - $4,604
159 Added 6.76%
2,511 $55,000
Q2 2020

Jul 31, 2020
SELL
$11.15 - $24.64 $199,997 - $441,967
-17,937 Reduced 88.41%
2,352 $55,000
Q1 2020

May 01, 2020
SELL
$8.75 - $16.3 $278,223 - $518,291
-31,797 Reduced 61.05%
20,289 $239,000
Q4 2019

Feb 14, 2020
SELL
$7.95 - $11.84 $359,936 - $536,056
-45,275 Reduced 46.5%
52,086 $552,000
Q3 2019

Nov 14, 2019
BUY
$10.82 - $14.25 $820,513 - $1.08 Million
75,833 Added 352.25%
97,361 $1.11 Million
Q2 2019

Aug 14, 2019
BUY
$7.95 - $11.25 $131,723 - $186,401
16,569 Added 334.12%
21,528 $242,000
Q1 2019

May 14, 2019
SELL
$5.95 - $10.19 $457,192 - $782,989
-76,839 Reduced 93.94%
4,959 $40,000
Q4 2018

Feb 14, 2019
BUY
$5.91 - $9.29 $442,422 - $695,449
74,860 Added 1078.99%
81,798 $517,000
Q3 2018

Nov 14, 2018
BUY
$6.4 - $9.85 $34,412 - $52,963
5,377 Added 344.46%
6,938 $68,000
Q2 2018

Aug 14, 2018
SELL
$6.9 - $9.9 $368,108 - $528,155
-53,349 Reduced 97.16%
1,561 $13,000
Q1 2018

May 15, 2018
BUY
$7.2 - $10.05 $274,356 - $382,955
38,105 Added 226.75%
54,910 $396,000
Q4 2017

Feb 14, 2018
SELL
$7.25 - $15.65 $58,340 - $125,935
-8,047 Reduced 32.38%
16,805 $137,000
Q3 2017

Nov 14, 2017
BUY
$12.0 - $15.0 $250,692 - $313,365
20,891 Added 527.42%
24,852 $361,000
Q2 2017

Aug 14, 2017
SELL
N/A
-10,320 Reduced 72.26%
3,961 $48,000
Q1 2017

Nov 14, 2017
BUY
N/A
14,281
14,281 $183,000

Others Institutions Holding CYTK

# of Institutions
445
Shares Held
129M
Call Options Held
5.25M
Put Options Held
1.18M
View Full List

About CYTOKINETICS INC

CYTK Quotes by TradingView
  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $6.25B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email